For Your Kitchen
Cookbooks

Everyday recipes with room for flavor, variety, and real life. Dinner should not feel like homework.

Taste it

Sponsorship complete. Dine on...

Nutrition, wellness, weight loss, and calmer healthy living.

Oral GLP-1 Medications Could Transform Diabetes Treatment in the Global South

Nov 14, 2026
Oral GLP-1 Medications Could Transform Diabetes Treatment in the Global South

A significant transformation is occurring in the treatment of diabetes, as medications that have long been administered via injections are now transitioning to oral pills. This shift could fundamentally change how diabetes and obesity are treated, particularly in the Global South, where access to healthcare resources can be limited. The introduction of oral GLP-1 (glucagon-like peptide-1) receptor agonists represents a promising alternative to traditional injectable therapies, which have been the standard for years.

GLP-1 medications have been pivotal in managing uncontrolled diabetes. The first of these drugs, Exenatide, was approved by the FDA in 2005, followed by Liraglutide in 2009. Until recently, the market has been dominated by weekly injections such as Ozempic and Wegovy, which have also shown effectiveness in promoting weight loss. However, the emergence of once-daily oral GLP-1 pills could significantly enhance accessibility for patients in regions where injectable medications are not feasible due to cost or the need for cold storage.

For Your Kitchen
Cookbooks
Taste it
Kitchen Scales
Taste it
Meal Prep Containers
Taste it

Sponsorship complete. Dine on...

Currently, approximately one in nine adults globally lives with diabetes, and the prevalence of obesity is also alarming, affecting one in eight individuals. The high costs associated with injectable GLP-1 medications, which can reach up to $500 per month in the United States and similar prices in other countries, have made them largely inaccessible for many patients. In contrast, the oral versions, such as locally manufactured oral semaglutide, can be available for as little as $18 for a 30-day supply, making them a more viable option for those in need.

Countries like Pakistan, which has the highest diabetes prevalence in the world at 31.4%, could particularly benefit from this shift. The affordability and ease of distribution of oral medications could help bridge the treatment gap for millions suffering from diabetes and obesity. Dr. Zakir Alavi, an endocrinologist in Karachi, emphasizes the dual burden of malnutrition and obesity in Pakistan, highlighting the need for effective treatments that can address both issues. He notes that GLP-1 medications have revolutionized diabetes management, not only aiding in weight control but also improving various health outcomes related to obesity.

Why Potential Matters Here

The potential for oral GLP-1 medications to transform diabetes treatment is underscored by the insights of experts like Rayaz Malik, a professor of medicine at Weill Cornell Medicine in Qatar. Malik points out that significant weight loss, often around 15 kg, is necessary to achieve remission from diabetes, and the wider availability of these medications could facilitate this for many patients. Jens Juul Holst, a key figure in the development of GLP-1 therapies, reflects on the groundbreaking nature of these medications, which mimic the body's natural processes to regulate insulin and appetite.

Navigating Challenges and Future Prospects for Diabetes Treatment

Despite the promise of oral GLP-1 medications, challenges remain. These pills must survive the digestive process to be effective, which necessitates taking them on an empty stomach and at higher doses compared to injections. Newer formulations are being developed to overcome these limitations, and the future looks hopeful for more accessible diabetes treatments.

The implications of this shift extend beyond diabetes management; they could also play a crucial role in addressing the global obesity epidemic, which the World Health Organization has recognized as a significant public health concern. With the potential for GLP-1 medications to become more widely available in oral form, the landscape of diabetes and obesity treatment may be on the verge of a major breakthrough, promising improved health outcomes for millions around the world.

For Your Kitchen
Cookbooks
Taste it
Kitchen Scales
Taste it
Meal Prep Containers
Taste it
Vegetable Prep & Salad Spinners
Taste it

Sponsorship complete. Dine on...

For Your Kitchen
Cookbooks

Everyday recipes with room for flavor, variety, and real life. Dinner should not feel like homework.

Taste it
Kitchen Scales

Kitchen scales for recipes that deserve more precision than 'that looks about right.'

Taste it
Meal Prep Containers

Give tomorrow's lunch a proper home. Containers for meals worth looking forward to.

Taste it
Vegetable Prep & Salad Spinners

Salad spinners and vegetable-prep tools for everyday salads, bowls, and side dishes. A little less kitchen setup, a little more time to enjoy the meal.

Taste it
Blenders & Smoothie Tools

Blenders for fruit, yogurt, soups, and the combinations you actually enjoy. Everyday kitchen tools, not a promise in a glass.

Taste it
Sheet Pans & Roasting Essentials

Sheet pans and roasting racks for vegetables and simple oven meals. Useful equipment for dinner without an elaborate production.

Taste it

Sponsorship complete. Dine on...

Across our publications

In Other News

Latest stories from other publications.

Explore all publications (opens in a new tab)